Among patients who are double negative for AChR-Ab and MuSK-Ab, 2–19% are positive for low-density lipoprotein receptor-related protein 4 antibody (LRP4-Ab) (11, 12), known as LRP4-MG. This evidence concerns the gene LRP4 and myasthenia gravis.